53631-13-3

Basic information

• Product Name: Ethanone, 2-broMo-1-(3,5-dichlorophenyl)- (Related Reference)
• Synonyms: Ethanone, 2-broMo-1-(3,5-dichlorophenyl)- (Related Reference);2-Bromo-3',5'-dichloroacetophenone
• CAS NO: 53631-13-3
• Molecular Formula: C₈H₅BrCl₂O
• Molecular Weight: 267.9347
• Mol File: 53631-13-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 334.1±37.0 °C(Predicted)
• Appearance: /
• Density: 1.695±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Ethanone, 2-broMo-1-(3,5-dichlorophenyl)- (Related Reference)(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 2-broMo-1-(3,5-dichlorophenyl)- (Related Reference)(53631-13-3)
• EPA Substance Registry System: Ethanone, 2-broMo-1-(3,5-dichlorophenyl)- (Related Reference)(53631-13-3)

Safety Data

• Hazardous Substances Data: 53631-13-3(Hazardous Substances Data)

Usage

General Description

Ethanone, 2-bromo-1-(3,5-dichlorophenyl)- is a specific chemical compound that is referenced in scientific literature. It is a brominated derivative of ethanone, also known as acetone, and contains a 3,5-dichlorophenyl group. Ethanone, 2-broMo-1-(3,5-dichlorophenyl)- (Related Reference) may be used in research or industrial applications as a precursor or reagent in organic synthesis. Its properties and potential uses in various fields may be further explored in the related reference.

Upstream product

• 14401-72-0 3',5'-dichloroacetophenone 
• 2905-62-6 3,5-dichlorobenzoyl chloride 

Downstream Products

• 1444617-06-4 C₂₅H₁₇Cl₂NO₄ 
• 154260-27-2 1-(3,5-dichlorophenyl)-2-methylthio-1-ethanone 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Fungicidal arylpyrazoles

The present invention relates to new derivatives of the family of 3-arylpyrazoles of formula (I), their methods of preparation, the compositions containing them and their utilization for the protection of plants against fungal diseases. STR1

Process for producing optically active carbinols

The present invention relates to a process for producing optically active halomethyl phenyl carbinols of the formula (1), comprising reducing halomethyl phenyl ketones of the formula (2) using an asymmetric reducing agent obtained from boranes and optically active α-phenyl-substituted-β-amino alcohols of the formula (3) or optically active α-non-substituted-β-amino alcohols of the formula (4). The present invention further relates to a process for producing optically active carbinols, comprising reacting a prochiral keytone with an asymmetric reducing agent obtained from optically active β-amino alcohols of the formula (5), a metal boron hydride and Lewis acid or lower dialkyl sulfuric acid. All of the formulas (1) to (5) are the same as shown in the specification.